PriceTargets.com logo

Oaktree Acquisition Corp. III Life Sciences - OACC Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$10.57 As of 12/4/2025 04:43 PM ET
+0 (0.00%)

This chart shows the closing price for OACC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oaktree Acquisition Corp. III Life Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OACC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OACC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Oaktree Acquisition Corp. III Life Sciences in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $10.57.

This chart shows the closing price for OACC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 contributing investment analysts is to sell stock in Oaktree Acquisition Corp. III Life Sciences.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
(Data available from 12/5/2020 forward)

News Sentiment Rating

1.67 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Oaktree Acquisition Corp. III Life Sciences logo
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Read More

Today's Range

Now: $10.57
Low: $10.55
High: $10.58

50 Day Range

MA: $10.57
Low: $10.50
High: $10.64

52 Week Range

Now: $10.57
Low: $9.95
High: $10.85

Volume

2,837 shs

Average Volume

56,088 shs

Market Capitalization

$236.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oaktree Acquisition Corp. III Life Sciences?

The following sell-side analysts have issued reports on Oaktree Acquisition Corp. III Life Sciences in the last year: Weiss Ratings.
View the latest analyst ratings for OACC.

What is the current price target for Oaktree Acquisition Corp. III Life Sciences?

0 Wall Street analysts have set twelve-month price targets for Oaktree Acquisition Corp. III Life Sciences in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Oaktree Acquisition Corp. III Life Sciences in the next year.
View the latest price targets for OACC.

What is the current consensus analyst rating for Oaktree Acquisition Corp. III Life Sciences?

Oaktree Acquisition Corp. III Life Sciences currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe OACC will underperform the market and that investors should sell shares of Oaktree Acquisition Corp. III Life Sciences.
View the latest ratings for OACC.

What other companies compete with Oaktree Acquisition Corp. III Life Sciences?

Other companies that are similar to Oaktree Acquisition Corp. III Life Sciences include Uniti Group, Franklin BSP Realty Trust, Permian Basin Royalty Trust, Southport Acquisition and NexPoint Residential Trust. Learn More about companies similar to Oaktree Acquisition Corp. III Life Sciences.

How do I contact Oaktree Acquisition Corp. III Life Sciences' investor relations team?

Oaktree Acquisition Corp. III Life Sciences' physical mailing address is 333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CA, 90071. The company's listed phone number is (213) 830-6300 and its investor relations email address is [email protected]. The official website for Oaktree Acquisition Corp. III Life Sciences is www.oaktreeacquisitioncorp.com. Learn More about contacing Oaktree Acquisition Corp. III Life Sciences investor relations.